Yvonne Mcgrath
Chief Scientific Office
Preclinical Development
Complix
Belgium
Biography
Dr. Yvonne Mcgrath has been the Chief Scientific Officer of Complix NV since May 2014. Dr. McGrath served as Head of Development at Immunocore and also served as Head of Preclinical Development and CMC. In these positions, she successfully developed and executed the late preclinical and early clinical strategy for a novel platform technology, managed meetings with European and US regulatory authorities and led manufacturing and CMC strategy for a new biological entity targeting cancer. Her previous experience includes being a Project Manager at the UK subsidiary of the German biotech company MediGene AG, and Senior Scientist at BioVex (now part of Amgen). Dr. McGrath has a PhD from the University of Wales, College of Medicine.
Research Interest
biotech
